Abstract
HYPERPARATHYROIDISM was discovered nearly simultaneously in Europe and America just forty years ago (1925 and 1926).1 2 3 4 5 The manner of discovery on either side of the Atlantic was basically different. Neither side was aware of what was happening on the other, but all on both sides thought of it then as a disease of bone and rare. Over the years, however, we have come to realize that the primary glandular disorder appears in a variety of clinical forms and the disease is by no means uncommon. It was the American approach to the discovery that led to the wider recognition of . . .